Close
ACHEMA MIDDLE EAST 2026

World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031

The global cell and gene therapy (CGT) supply chain and logistics industry is predicted to reach $3.12 billion by 2031, based on a market...

Cell-Energy Activity In Organs, Tissues By New MRI Method

Each cell in the body puts in considerable energy to maintain the proper balance of water and critical electrolytes in order to survive. Researchers...

Seamlessness In Patient Engagement Through eConsent Trial

For the very first time, drug research participants can go on to give digital consent when it comes to their participation. This will take...

Australia Sepsis Study To Aid In New Antibiotic Discovery

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new...

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within...

AI Assesses The Enzyme Functions Finer Than Leading Tools

A novel artificial intelligence tool can help predict the functions of enzymes on the basis of their amino acid sequences, even when the enzymes...

Regulatory Actions Needed For Gaps In Cancer Drug Info

Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...